Clinical study shows postbiotic urolithin a improves muscle strength and exercise performance in middle aged adults -

Amazentis, a spin-off of EPFL, the Swiss Federal Institute of Technologyin Lausanne, pioneering scientific breakthroughs in cellular health and nutrition, announced today that the peer-reviewed clinical and translational journal Cell Reports Medicine published new clinical results showing the muscle health benefits of the gut microbiome postbiotic Urolithin A.